BONE BIOLOGICS CORP (BBLG) Forecast, Price Target & Analyst Ratings

NASDAQ:BBLG • US0980706008

Current stock price

1.23 USD
-0.03 (-2.38%)
At close:
1.2217 USD
-0.01 (-0.67%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BONE BIOLOGICS CORP (BBLG).

Forecast Snapshot

Consensus Price Target

Price Target
$22.64
+ 1,740.98% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.55
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$22.64
Upside
+ 1,740.98%
From current price of $1.23 to mean target of $22.64, Based on 7 analyst forecasts
Low
$22.42
Median
$22.64
High
$23.31

Price Target Revisions

1 Month
-0.22%
3 Months
-0.22%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for BBLG. The average price target is 22.64 USD. This implies a price increase of 1740.98% is expected in the next year compared to the current price of 1.23.
The average price target has been revised downward by 0.22% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BBLG Current Analyst RatingBBLG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

BBLG Historical Analyst RatingsBBLG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
BBLG was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBLG.
In the previous month the buy percentage consensus was at a similar level.
BBLG was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-04-13EF HuttonReiterate Buy
2023-04-03EF HuttonReiterate Buy
2022-10-18EF HuttonInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.55
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
71.31%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
N/A

Next Earnings Summary

BBLG is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.55 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
BBLG revenue by date.BBLG revenue by date.
N/AN/A
EBITDA
YoY % growth
BBLG ebitda by date.BBLG ebitda by date.
-12M-20.41M
-70.08%		-2.63M
87.11%		-2.79M
-6.08%		-2.45M
12.19%		-830K
66.12%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
BBLG ebit by date.BBLG ebit by date.
-12M-20.41M
-70.08%		-2.63M
87.11%		-2.79M
-6.08%		-2.45M
12.19%		-830K
66.12%		-1.1M
-32.53%		-3.67M
-233.64%		-9.428M
-156.90%		-4.219M
55.25%		-3.235M
23.33%		N/A
5.66%		N/A
-3.44%
Operating Margin
BBLG operating margin by date.BBLG operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BBLG eps by date.BBLG eps by date.
N/AN/AN/AN/AN/AN/AN/A-604.80
37.61%		-398.34
34.14%		-29.78
92.52%		-3.76
87.38%		N/A
47.64%		N/A
16.06%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.55
71.31%		-0.51
61.65%		-0.47
-26.81%		-0.44
-213.29%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-757.86K
27.02%		-768.06K
-2.67%		-778.26K
-8.80%		-789.48K
-7.69%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BBLG Yearly EPS VS EstimatesBBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -200 -400 -600 -800

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BONE BIOLOGICS CORP / BBLG Forecast FAQ

What do analysts expect the price target to be for BONE BIOLOGICS CORP (BBLG)?

7 analysts have analysed BBLG and the average price target is 22.64 USD. This implies a price increase of 1740.98% is expected in the next year compared to the current price of 1.23.

Can you provide the upcoming earnings date for BONE BIOLOGICS CORP?

BONE BIOLOGICS CORP (BBLG) will report earnings on 2026-05-11.

What are the consensus estimates for BONE BIOLOGICS CORP (BBLG) next earnings?

The consensus EPS estimate for the next earnings of BONE BIOLOGICS CORP (BBLG) is -0.55 USD and the consensus revenue estimate is 0 USD.